Ross Law

3 days ago | finance.yahoo.com | Ross Law

The Trump Administration in the US has introduced legislation outlining plans for deep cuts and limitations to Medicaid, which observers warn could impact millions of America's most vulnerable citizens over the next decade. The budget reconciliation bill, released late on 11 May by the US Committee on Energy and Commerce, estimates that proposed cuts to the health insurance programme will save the federal government around $900bn over the next decade.

3 days ago | medicaldevice-network.com | Ross Law

Quantum computing, the next evolution of classical computing, holds the potential to unlock new capabilities by redefining how information is processed. This month’s cover feature looks at the potential of quantum computing in overcoming complex biomedical challenges as the technology begins to progress from the lab to the clinic.

4 days ago | medicaldevice-network.com | Ross Law

Fujifilm Healthcare Americas has extended its partnership with the National Rural Health Association (NRHA) for three more years, continuing efforts to provide advanced imaging equipment to healthcare facilities within rural US communities. Fujifilm said it will work alongside the NRHA to ensure that its member facilities have access to the same advanced medical imaging systems across modalities including ultrasound, mammography, digital radiography that are found in urban healthcare sites.

4 days ago | medicaldevice-network.com | Ross Law

Israeli startup Mentaily has raised $3m in seed financing to advance the development of LIV, a mental health diagnosis and support tool. Underpinned by generative artificial intelligence (genAI), LIV is a chat tool that offers personalised support to individuals struggling with PTSD, psychological trauma, and other mental health conditions.

1 week ago | finance.yahoo.com | Ross Law

The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement generative artificial intelligence (genAI) across the agency by 30 June 2025. According to the agency, the technology has amply demonstrated its value in enabling FDA personnel to spend less time on “tedious, repetitive tasks that often slow down the review process”. The news follows a pilot of genAI’s application in scientific review tasks.